Loading...
XNAS
MOBI
Market cap322mUSD
Sep 21, Last price  
9.71USD
1D
-7.87%
1Q
-29.28%
IPO
-19.08%
Name

Mobia Medical Inc

Chart & performance

D1W1MN
XNAS:MOBI chart
P/E
P/S
EPS
Div yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
32m
32,040,978
Net income
-46m
-46,498,188
CFO
-46m
-45,694,990

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Key people

Jordan Curnes
Co - Founder, President · since 2023
Richard Foust
CEO
Mary Williams
Vice President - Commercial Ops & Analytics
Brent Tarver
Vice President, Clinical Affairs · since 2023
IPO date
May 08, 2026
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FY
2025‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT